Novartis Finance S.A. completed the placement of €750,000,000 Guaranteed Notes due 2023, €750,000,000 Guaranteed Notes due 2030 and €750,000,000 Guaranteed Notes due 2038. The 2023 Notes were issued at 99.655% of their principal amount with an interest of 0.500% and will mature on 14 August 2023 at their nominal value. The 2030 Notes were issued at 99.957% of their principal amount with an interest of 1.375% and will mature on 14 August 2030. The 2038 Notes were issued at 99.217% of their principal amount with an interest of 1.700% and will mature on 14 August 2038. The Notes are guaranteed by Novartis AG. They have been provisionally admitted to trading at the SIX Swiss Exchange and are expected to be listed there as well.

Barclays Bank, BNP Paribas and Deutsche Bank AG, London Branch acted as Joint Lead Managers and HSBC Bank plc, Société Générale and The Royal Bank of Scotland plc (trading as NatWest Markets) as Co-Managers.

Bär & Karrer acted as Swiss legal adviser to Novartis in this transaction. The team included Thomas U. Reutter, Alexander von Jeinsen and Daniel Raun (all Capital Markets) as well as Susanne Schreiber and Cyrill Diefenbacher (both Tax).